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In the past few decades, various novel actions of vitamin D have been discovered. 
The mechanism of action of calcitriol or vitamin D is mediated by the Vitamin D  
receptor (VDR), a subfamily of nuclear receptors, which acts as a transcription 
factor in the target cells after formation of a heterodimer with the retinoid X 
receptor (RXR). As the VDR has been found in virtually all cell types, vitamin D 
exerts multiple actions on different tissues. Vitamin D has important immuno-
modulatory actions, which includes enhancement of the innate immune system and 
inhibition of the adaptative immune responses. These actions are associated with 
an increase in production of interleukin (IL)-4 by T helper (Th)-2 lymphocytes 
and the up-regulation of regulatory T lymphocytes. Vitamin D can regulate the 
immune responses in secondary lymphoid organs as well as in target organs through 
a number of mechanisms. Vitamin D inhibits the expression of APC cytokines, 
such as interleukin-1 (IL-1), IL-6, IL-12, and tissue necrosis factor- α (TNF-α) and 
decreases the expression of a set of major histocompatibility complex (MCH) class 
II cell surface proteins in macrophages. Vitamin D also inhibits B cell differentiation 
and antibody production. These actions reflect an important role of Vitamin D in 
balancing the immune system.
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1. Introduction
Vitamin D is now recognized as a vitamin as well as a pro hormone. It exists in 
two major forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). 
Vitamin D3 is formed in the human skin and is obtained in the diet through the intake 
of animal-based foods such as fish oils, whereas vitamin D2 is present in plant sources 
[1]. Vitamin D is traditionally known to be involved in the regulation of calcium and 
phosphate metabolism. Apart from its role in maintaining bone mineralization, vita-
min D also has a well described function as an immunomodulatory hormone [2]. The 
Vitamin D receptor (VDR) and metabolizing enzymes are expressed by numerous 
types of immune cells such as lymphocytes, macrophages, monocytes and dendritic 
cells [3, 4]. Preliminary studies have revealed that vitamin D has noteworthy biologic 
activities on the innate and adaptive immune systems. Some preclinical studies have 
demonstrated that administration of vitamin D leads to changes in the occurrence 
and progression of many immune-related diseases [2, 5]. This is supported by clinical 
data that explains the possible association of vitamin D with the incidence of many 
disorders such as type 1 diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis 
and infectious diseases. The purpose of the present chapter is to provide a summary 
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of the effects of vitamin D on the immune system and the link between vitamin D 
and numerous types of immune-related diseases and conditions.
2. Vitamin D and the immune system
A significant role of vitamin D in the regulation of the immune system has been 
discovered in the last few decades. In 1983, the contribution of macrophages in 
producing vitamin D was documented by separation of VDR in activated human 
inflammatory cells [6, 7]. The role of vitamin D in the inhibition of T cell prolifera-
tion was discovered by Rigby, et al in 1984 [8]. Further evidences were found for 
elaborating the role of vitamin D in the regulation of the immune system [8].
T cells and B cells respond to 1, 25(OH)2D in a paracrine or autocrine manner in 
an immune environment. The action of 1,25(OH)2D on the inhibition of T helper 
cells was documented in preclinical studies. These effects include directly lowering 
the dendritic cell capability to activate T helper 17, inhibition of T helper 17-related 
IL-17 and hampering the ability to support T helper 17 polarization of naïve CD4+ 
T cells production [9]. In an autoimmune uveitis preclinical model, oral administra-
tion of 1,25(OH)2D prevented and inhibited immunological responses, as shown by 
reduction of both ROR-gamma-t (Retinoic acid Receptor-related Orphan Receptor 
gamma t) and IL-17 in CD4+ T cells, which are two indicators of T helper 17 cell 
function. Moreover, 1, 25(OH)2D inhibited bone marrow-derived dendritic cell 
ability to influence T helper 17 polarization of naive CD4+ T cells [9].
1, 25(OH)2D has also been involved in the inhibition of immunoglobulin pro-
duction and B cell proliferation and differentiation [10]. Low 1, 25(OH) [2] D level 
had been found in patients with systemic lupus erythematosus (SLE), suggesting 
that vitamin D could be involved in the regulation of autoantibody expression. 
Chen, et al showed that 1, 25(OH)2D has a direct effect on B cells, including inhi-
bition of proliferation, on generation of class-switched memory B cells and on 
immunoglobulin production in patients with SLE [10].
Vitamin D is also involved macrophage regulation and affects their cytokine 
expression. It increases prostaglandin E2 production from macrophages, which has 
a role in the inflammatory process and inhibits the expression of granulocyte-mac-
rophage colony-stimulating factor. Moreover, 1, 25(OH)2D induces macrophages 
and epithelial cells to produce cathelicidin, a peptide involved in antimicrobial 
action [11, 12]. Cathelicidin is responsible for activating the innate immune 
response by binding to its transmembrane receptor and is correlated to higher 
levels of the enzyme 1-alpha-hydroxylase in macrophages and keratinocytes [13]. 
The enzyme 1-alpha-hydroxylase further increases the production of cathelicidin 
through the production of 1,25(OH)2D.
Vitamin D is also involved in the activation of dendritic cells which enhance 
expression of CD4+/CD25+ regulatory T cells (T reg). In preclinical study by Gregori 
et al, 1, 25(OH)2D activated dendritic cells with a tolerogenic phenotype and caused 
an increased percentage of CD4+/CD25+ T reg in the spleen and lymph nodes. These 
regulatory T cells have a role in the transfer of transplantation tolerance [14].
3. Vitamin D and the innate immune system
Innate antigen presenting cells (APC), specifically dendritic cells (DC) are prin-
cipal targets for the immune modulatory effects of vitamin D. APCs have a crucial 
role in the initiation of the adaptive immune response as they present antigens to B 
cells and T cells and are able to modulate them by immunogenic signals such as the 
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expression of cytokines. Vitamin D and its analogs modify the function of DCs to 
induce a more tolerogenic and immature state. Immature DCs result in decreased 
levels of MHC class II and co-stimulatory molecule expression (CD40, CD80, 
CD86), which negatively affects antigen presentation accompanied by a lower IL-12 
secretion, but an increased production of the tolerogenic interleukin IL-10. High-
dose vitamin D supplementation in healthy humans (1 μg twice daily for 7 days) 
results in significant reduction in the proinflammatory cytokine IL-6 produced 
by peripheral mononuclear cells. A combination of all these effects results in the 
induction of potential regulatory T cells which are crucial for controlling immune 
responses and the development of autoreactivity [15]. A clinical study in 95 patients 
treated with adjunctive vitamin D therapy, added on to standard tuberculosis 
therapy demonstrated augmented resolution of inflammatory responses [16].
4. Vitamin D and the adaptive immune system
The expression of the nuclear VDR and vitamin D-activating enzymes in both 
T- and B types of human adaptive immune cells have been reported in studies. The 
activation and proliferation of T and B cells results in up-regulation of VDR expres-
sion, which ultimately regulates more than 500 vitamin D responsive genes [15].
Following are the proposed mechanisms for influence of vitamin D on T cell 
function [15]:
1. Direct, endocrine effects on T cells mediated via systemic vitamin D.
2. Direct, intracrine conversion of 25(OH) D to calcitriol by T cells.
3. Direct, paracrine effects of calcitriol on T cells following monocytes or 
 dendritic cells induced conversion of 25(OH) D to calcitriol.
4. Indirect effects on antigen presentation to T cells mediated via localized APCs 
by calcitriol.
All these effects of vitamin D result in shifting from a proinflammatory status to 
a more tolerogenic immune status, including very diverse effects on T cell subtypes: 
Vitamin D suppresses T helper cell proliferation, differentiation and modulates 
synthesis of cytokines [15].
5. Vitamin D and autoimmune diseases
Clinical studies investigated the association of vitamin D levels with the risk of 
developing autoimmunity and effect of vitamin D administration on autoimmune 
diseases. A systematic review of 219 studies demonstrated that vitamin D levels 
of<30 ng/mL are significantly associated with autoimmune disease. In patients with 
type-1 diabetes, the risks are significantly reduced in infants treated with vitamin D 
after the seventh month [17].
6. Vitamin D and Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease with T cell mediated 
destruction of pancreatic β-cells. It is hypothesized that Vitamin D supplementation 
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early in life could be protective therapy against the development of T1DM [18]. 
Vitamin D supplementation in the first year of life in children produced a 33% 
risk reduction of developing T1D in a subgroup analysis of the EURODIAB study 
[19]. A meta-analysis of four clinical studies also revealed a significantly reduced 
risk of development of T1D among infants receiving vitamin D supplementation 
[20]. Many trials on vitamin D and T1D are currently ongoing which will hopefully 
expand our understanding of this topic.
7. Vitamin D and multiple sclerosis
Hypovitaminosis D is one of the important risk factors for the increased risk of 
development of multiple sclerosis (MS). In a cohort of the Nurses’ Health Study 
(92953 women) and Nurses’ Health Study II (95310 women), the intake of Vitamin 
D ≥ 400 IU/day was associated with the reduced risk of developing MS. [21] In a 
study by Merja et al., vitamin D3 add on treatment to interferon β-1b reduces MRI 
disease activity in MS [22]. Currently ongoing studies such as SOLAR and the 
EVIDIMS study will explore many aspects of the role of vitamin D in the manage-
ment of MS in the coming years.
8. Vitamin D and psoriasis
Vitamin D is involved in the proliferation and maturation of keratinocytes. This 
action of vitamin D created interest as a topical therapeutic option in the treatment 
of psoriasis. A significant association between low vitamin D levels and psoriasis 
has been reported. Although the exact role of vitamin D in the pathogenesis of 
psoriasis is unclear, possible mechanisms include the regulation of the cutaneous 
immune system (inhibition of T cell proliferation, T reg induction) and down-
regulation of pro-inflammatory cytokines. However robust clinical data regarding a 
role of vitamin D in psoriasis is still awaited [23].
9. Vitamin D and rheumatoid arthritis
In addition to inhibiting inflammatory cytokines such as IL-6, TNFα, IL-17 in 
synovial fluid, vitamin D also reduces fibroblast erosion [24]. Vitamin D supple-
mentation was found to be associated with lower risk of RA in a prospective cohort 
of 29,368 women over a follow up period of 11 years [25]. A randomized controlled 
trial (RCT) by Buondonno et al. [26] evaluated the effect of administration of 
cholecalciferol on T helper cell sub-types and osteoclast precursors. Single dose 
of cholecalciferol (300,000 IU) along with standard treatment showed improve-
ments in inflammatory cytokines in this study [26]. Further studies are required to 
estimate the dose of Vitamin D in the treatment of RA.
10. Conclusion and future perspectives
The role of Vitamin D in autoimmune disease is a major area of research. 
Addressing questions as to whether vitamin D levels are related to the risk of develop-
ing autoimmunity and whether vitamin D supplementation can modify the course of 
autoimmune diseases, several studies performed over the last four decades support 
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the role of vitamin D in the prevention of autoimmune diseases. However there is still 
a need of randomized controlled clinical trials in this field. Upcoming clinical trials 
will find out the optimal mode and dosage of supplementation of vitamin D. However, 
with available data, vitamin D emerges as a promising nutrient in the prevention and 
adjunctive treatment of diseases caused by impaired immune-homeostasis.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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